GANX stock forecast for 2023 – 2027

Are you interested in Gain Therapeutics, Inc. stocks prediction? If yes, then on this page you will find useful information about the dynamics of the GANX stock price in 2022-2027. Is GANX a good long term stock? When should I take profit in Gain Therapeutics stock? Buy or sell stock? Will GANX stock price go up? What are analysts’ forecasts for GANX stock?
Forecst.com predicts future values using technical analysis of a large number of analytical parameters. GANX stock returns are also predicted based on historical data.

According to our research, GANX stock is a bad long-term investment. GANX share price has been in a bear cycle for the past year. Gain Therapeutics, Inc. stock trend is negative.

Gain Therapeutics company info

Industry Biotechnology
Address 4800 Montgomery Lane, Bethesda, MD, 20814, United States
Website https://www.gaintherapeutics.com

Forecasting

52 Week High: 4.26789 USD
52 Week Low: 0.000001 USD
1 Year Forecast: 0.00000101 USD
5 Year Forecast: 0 USD

Agilent Technologies info

Market Cap: 48.23M
52 Week Change: 0%
52 Week High: 17.93 USD
52 Week Low: 3.71 USD
Beta: 0
50 Day Moving Average: 5.11
90 Day Moving Average: 6.157
200 Day Moving Average: 7.08
Resistance Level: 4.34826
Pivot Point: 3.973
Support Level: 3.46626
Enterprise Value: 7,161,704
Forward P/E: -1.84
Forward EPS: -2.14
Profit Margin: 0.00%
Shares Outstanding: 11,879,700
EBITDA: -0.59
Held Percent Institutions: 11.68%
PEG Ratio (5Y): 0
Trailing EPS: -1.46

Gain Therapeutics stock forecasts for 2023-2027

DateOpen PriceClose PriceChange

Gain Therapeutics Stock Forecast for 2023

January 2023 0 0 0%
February 2023 0 0 0%
March 2023 0 0 0%
April 2023 0 0 0%
May 2023 0 0 0%
June 2023 0 0 0%
July 2023 0 0 0%
August 2023 0 0 0%
September 2023 0 0 0%
October 2023 0 0 0%

Other companies stock forecasts